MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

Filled with the top stories to start your day, and emergency news alerts.

Titan Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was ...

Victor Davis Hanson, a senior contributor for The Daily Signal, is a classicist and historian at the Hoover Institution at Stanford University and host of "The Victor Davis Hanson Show." His website, ...

After securing his 100th win over Santa Clarita Christian on Dec. 12, head coach Daniel Hebert led the Trinity Knights to a bounceback 75-49 win ...

Abstract: Given the recent surge in developments of deep learning, this paper provides a review of the state-of-the-art deep learning techniques for audio signal processing. Speech, music, and ...